Skip Navigation
Skip to contents

SSBH 2025

Today : 2025.08.26

D +89

As an international congress, all sessions, except those marked as Korean sessions (K), will be conducted in English.
K : Korean Session
Day 3
May 31(Sat)
09:00-10:10
Oral Presentation 3
Room 1
Chair(s)
Dong Jin Chung (Chonnam National University, Korea), Hyuntae Park (Dong-A University, Korea)
09:00-09:10 Chemokine CXCL9 Level is Associated with Greater Phenotypic Frailty in Older Women Da Hea Seo (Inha University College of Medicine, Korea)
09:10-09:20 Enhancing Fracture Risk Prediction by Integrating a Deep Learning Chest Radiography Model with FRAX Yisak Kim (Seoul National University Graduate School, Korea)
09:20-09:30 Association between Gut Microbiota Status and Prior Fracture in Postmenopausal Women? the MICROBONE Study Szulc Pawel (University of Lyon, Hospics Civils de Lyon, France)
09:30-09:40 Long-Term Impact of Hip Fractures on Life Expectancy: A Nationwide Korean Cohort Study Kyoung Jin Kim (Korea University, Korea)
09:40-09:50 Genetic Variation of Vitamin D Binding Protein in Patients with Carpal Tunnel Syndrome Affects their Responses to Vitamin D Supplementation Ji Sup Hwang (Seoul National University Hospital, Korea)
09:50-10:00 Is Denosumab Necessary After Parathyroidectomy in Primary Hyperparathyroidism? A Retrospective Analysis Seyoun Park (Severance hospital, Korea)
10:00-10:10 Osteoporosis Evaluation and Management Status after Distal Radius Fracture: A Real-World Data Young Ho Shin (Asan Medical Center, University of Ulsan College of Medicine, Korea)
Day 3
May 31(Sat)
09:00-10:10
Oral Presentation 4
Room 2
Chair(s)
Je-Yong Choi (Kyungpook National University, Korea), Serk In Park (Korea University, Korea)
09:00-09:10 Flavonoid-Mediated Regulation of a PGC1α-Dependent Myokine and Mitochondrial Function in Chemotherapy-Induced Muscle Atrophy Hyeyoon Kim (Sookmyung Women's University, Korea)
09:10-09:20 The Inhibitory Effects of Tosyl Phenylalanyl Chloromethyl Ketone on Alveolar Bone Loss in Experimental Periodontitis in Mice Sharma Sangita (Chonnam National University, School of Dentistry, Korea)
09:20-09:30 Myostatin Functions as a Direct Regulator of Adipogenesis Jongmin Baik (School of Dentistry and Dental Research Institute, Seoul National University, Korea)
09:30-09:40 Enhancing Achilles Tendon Healing Through Localized NAD+ Boosting with NR-Loaded Hydrogel Wei Shibo (GIST, Korea)
09:40-09:50 The Role of TGF-β in Interconversion between Mature Osteoblasts and Bone Lining Cells Ahyoun Choi (Seoul National University, Korea)
09:50-10:00 The Effects of Cathepsin K Inhibitors on Osteoclastic Bone Resorption, Cell Fusion, and Osteoclast-Osteoblast Communication: A Time-Lapse Study Bromme Dieter (University of British Columbia, Canada)
10:00-10:10 Human Dental Pulp Stem Cell-Derived Extracellular Vesicles Attenuate Inflammation and Alveolar Bone Loss in Periodontitis Hyekyoung You (Chonnam National University School of Dentistry, Korea)
Day 3
May 31(Sat)
09:00-09:50
Meet the Expert 3
Room 3
09:00-09:50 Vertebral Fracture Recognition for Non-Radiologists William D. Leslie (University of Manitoba, Canada)
Day 3
May 31(Sat)
10:15-11:05
Plenary Lecture 3
Room 1
Emerging evidence indicates that the cells of skeletal system demand large amount of energy for the development and function. The understanding of integrated mechanisms of energy metabolism and bone cells has been greatly enhanced by combined approaches using sophisticated modern analytical tools that enable the quantification of metabolic intermediates and advanced mouse genetic approaches that allow investigation into diverse molecular mechanisms. Dr. Thomas Clemens’ research is focused on the identification of cellular and molecular mechanisms by which osteoblast differentiation and activities are regulated and integrated with energy metabolism and homeostasis. In the current session, Dr. Clemens will discuss historical and contemporary studies that expands our knowledge of the metabolic properties of osteoblasts and their complex interactions with the metabolic and endocrine networks of the body. These novel insights will contribute to better understand the skeletal bioenergetics and its physiological significance in human health and diseases, especially in face of the increasing prevalence of diabetes and other metabolic disorders worldwide.
Chair(s)
Deog Yoon Kim (Kyung Hee University, Korea)
10:15-11:05 Osteoblast Bioenergetics and Skeletal Energy Metabolism Thomas L. Clemens (University of Maryland, USA)
Day 3
May 31(Sat)
11:20-12:35
Symposium 4. Rare Bone Diseases: Unraveling Challenges and Advancing Solutions
Room 1
Rare Bone Diseases (RBD) represent a particularly challenging area in diagnosis and treatment. Without timely detection and proper management, patients can endure significant suffering and long-term complications. This symposium will provide an in-depth exploration of the pathophysiology and advanced therapeutic approaches for RBDs, with distinguished experts from around the world sharing their insights and experiences. The first lecture, From Pathophysiology to Treatment: Burosumab in XLH Management, will delve into the pathophysiology of X-linked hypophosphatemia (XLH) and introduce the latest therapeutic strategies using Burosumab. The second lecture, Get Straight to the Source of Hypophosphatasia, will discuss the root causes of hypophosphatasia and share the latest treatment advancements targeting this condition. The final lecture, Rare Bone Diseases in Korea: Current Challenges and Future Directions, will analyze the challenges faced by patients with rare bone diseases in Korea and propose future solutions. Rare bone diseases have a profound impact on patients’ lives, yet they are often overlooked. This session aims to raise awareness of these conditions and provide valuable opportunities to improve the diagnosis and care of RBD patients.
Chair(s)
Young-Joo Kwon (Korea University, Korea), Ha Young Kim (University of Ulsan, Korea)
11:20-11:45 New Horizons in XLH Management: Burosumab and Beyond Adalbert Raimann (Medical University of Vienna, Austria)
11:45-12:10 Get Straight to the Source of Hypophosphatasia Eric Rush (Children's Mercy Kansas City, USA)
12:10-12:35 Rare Bone Disease in Korea: Current Challenges and Future Directions Yumie Rhee (Yonsei University, Korea)
Day 3
May 31(Sat)
11:20-12:35
Symposium 5. KSBMR-KCR Joint Symposium: Osteoimmunology
Room 2
Osteoimmunology is a field that studies the complex interactions between the skeletal and immune systems, playing a crucial role in understanding the pathogenesis of various bone and immune-related diseases. The signaling processes between immune cells and bone cells regulate bone formation and resorption, with inflammatory cytokines and immune regulatory factors playing essential roles in these processes. Recent studies indicate that changes in the immune system are closely linked to the progression of diseases such as osteoporosis, rheumatoid arthritis, and osteoarthritis, leading to the development of novel therapeutic strategies. In particular, active research is being conducted on the regulatory mechanisms of macrophages and osteoclasts, the relationship between circadian rhythms and bone metabolism, and the impact of inflammatory responses on bone loss.
This KSBMR-KCR Joint Symposium will introduce the latest research in the field of osteoimmunology, focusing on the mechanisms by which macrophage-derived osteoclasts regulate the balance between bone resorption and formation and their role in inflammatory arthritis. Additionally, the symposium will comprehensively examine the importance of maintaining osteoimmune homeostasis based on the interaction between immune responses and bone metabolism. Furthermore, it will analyze the effects of immune cells and circadian rhythm changes on cartilage and bone tissue, proposing therapeutic strategies for bone diseases. These studies provide critical foundational knowledge for developing immune regulation-based treatments for refractory bone diseases, demonstrating the essential role of osteoimmune approaches in the future treatment of bone metabolic diseases. Moreover, by integrating research in bone metabolism and immunology, this symposium aims to deepen the understanding of the pathological mechanisms of bone diseases and propose new directions for osteoimmune-based therapeutic development.
Chair(s)
Chan Soo Shin (Seoul National University, Korea), Seung Cheol Shim (Chungnam National University, Korea)
11:20-11:45 Macrophages in the Regulation of Osteoimmune Homeostasis Eun-Ju Chang (University of Ulsan, Korea)
11:45-12:10 Peripheral Circadian Rhythm Disruption as a Potential Driver of Age-Related ECM Destruction in Osteoarthritis Je-Hwang Ryu (Chonnam National University, Korea)
12:10-12:35 Molecular and Cellular Basis of Joint Destruction in Rheumatoid Arthritis Seungwoo Han (Kyungpook National University, Korea)
Day 3
May 31(Sat)
11:20-12:35
Working Group 3. Fracture Working Group K
The Update of Treatment of Osteoporotic Fractures Room 3
Chair(s)
Jae-Hwi Nho (Soonchunhyang University, Korea)
11:20-11:45 The Update of Treatment of Osteoporotic Vertebral Fractures Joonghyun Ahn (The Catholic University of Korea, Korea)
11:45-12:10 The Update of Treatment of Osteoporotic Hip Fractures Se-Won Lee (The Catholic University of Korea, Korea)
12:10-12:35 The Update of Treatment of Osteoporotic Knee Fracture Dong-Geun Kang (Yeson Hospital, Korea)
Day 3
May 31(Sat)
12:35-12:50
Luncheon Symposium 4
Room 1
Chair(s)
Keeho Song (Konkuk University, Korea)
12:35-12:50 Efficacy & Safety from a Global Phase 3 Trial Including Korean: Obodence®(Denosumab Biosimilar) So Young Park (Kyung Hee University, Korea)
Day 3
May 31(Sat)
13:35-14:45
Oral Presentation 5
Room 1
Chair(s)
Gun-Il Im (Dongguk University, Korea), Yoon-Kyoung Sung (Hanyang University, Korea)
13:35-13:45 Genetic and Clinical Characteristics of Korean Adults with X-Linked Hypophosphatemia and Their Patient-Reported Outcomes: A Prospective Study Seung Shin Park (Seoul National University College of Medicine, Korea)
13:45-13:55 Exploring the Distinct Signaling Pathways Activated by Dimeric [R25C]PTH(1-34) and Its Therapeutic Potential Minsoo Noh (Gachon University College of Medicine, Korea)
13:55-14:05 DPC Score and Skeletal Muscle Index as Predictors of One-Year Total Hip Bone Loss in Kidney Transplant Recipients: The SMART Cohort Jin Ah Park (Yonsei University College of Medicine, Korea)
14:05-14:15 Associations between Paraben Exposure and Skeletal Muscle Mass in the Adult Population: Evidence from the 2013-2016 NHANES Kun-Hee Oh (Seoul National University, College of Medicine, Korea)
14:15-14:25 Gait Analysis as a Biomarker for Early Detection of Sarcopenia and Possible Sarcopenia: Statistical Analysis and Model Validation Jung Woo Lee (Yonsei University Wonju College of Medicine, Korea)
14:25-14:35 Increased Fracture Risk and Mortality in Patients with Parkinson’s Disease: A Retrospective Cohort Study So Young Park (Kyung Hee University College of Medicine, Korea)
14:35-14:45 Prevalence and Management of Osteoporosis on the Patients with Elective Total Hip Arthroplasty Tae-Young Kim (Konkuk University, Korea)
Day 3
May 31(Sat)
13:35-14:45
Oral Presentation 6
Room 2
Chair(s)
Hong-Hee Kim (Seoul National University, Korea), Seoung Hoon Lee (Wonkwang University, Korea)
13:35-14:45 Circadian Rhythm Disruption Exacerbates Periodontitis through DEC1 Upregulation Weon-Young Choi (Chonnam National University, Korea)
13:45-13:55 Saucerneol D Attenuates Osteoclastogenesis and ROS Activities by Suppressing MAPK/NF-κB/Akt and Enhancing AMPK/Nrf2/FoxO1 Signaling Pathways Rira Oh (Sookmyung Women's University, Korea)
13:55-14:05 A Novel Role of Cbfβ in Vascular Smooth Muscle Cells for Bone and Vascular Homeostasis Xian Jin (Kyungpook National University, Korea)
14:05-14:15 Probiotics Ameliorate Inflammatory Bone Loss under Estrogen-Deficient Conditions via Short Chain Fatty Acids (SCFAs) Bhardwaj Asha (All India Institute of Medical Sciences (AIIMS), India)
14:15-14:25 Effects of Combined Exercise on Bone Metabolism-Related Gene Expression in Mice: Microarray Analysis Jiyeon Kim (Cleveland Clinic Lerner Research Institute, United States)
14:25-14:35 Spatial Transcriptomic Profiling of the Immune Landscape in Multiple Myeloma Reveals a Tumor-promoting Role for Eosinophils Jeremy S. Frieling (H. Lee Moffitt Cancer Center and Research Institute, USA)
14:35-14:45 Single Cell RNA-seq Analysis of The Young vs. Aged Murine Multiple Myeloma Reveals Key Changes in The Bone Microenvironmental Landscape Nyman Karl (H. Lee Moffitt Cancer Center and Research Institute, United States)
Day 3
May 31(Sat)
13:35-14:25
Meet the Expert 4
Room 3
13:35-14:25 Evidence for a Bone-Brain Connection Theresa A. Guise (The University of Texas MD Anderson Cancer Center, USA)
Day 3
May 31(Sat)
15:00-16:15
Symposium 6. The Next Frontier in Bone Health: Exploring Anabolic Strategies Across Contexts
Room 1
Anabolic therapies represent a groundbreaking paradigm in osteoporosis treatment by promoting bone formation, distinguishing themselves from traditional therapeutic approaches. This symposium will comprehensively explore the latest knowledge and clinical applications of anabolic therapies. The first lecture, Effects of Anabolics on Bone: Bridging the Gap Between Clinical Trials and Real-World Practice, will compare outcomes from clinical trials with real-world practice and discuss appropriate therapeutic strategies for effective implementation. The second lecture, Transforming Fracture Care: Paradigm Shifts with Anabolic Therapies, will focus on how anabolic therapies are driving paradigm shifts in fracture care, offering innovative approaches for treatment. The final lecture, Anabolics in Cancer Patients: To Use or Not to Use?, will analyze the potential benefits and risks of using anabolic therapies in cancer patients, exploring their feasibility in this unique population. This session aims to re-evaluate the potential of anabolic therapies and provide valuable insights into optimizing their use in clinical practice to achieve better patient outcomes.
Chair(s)
Kyuri Hwang (Seoul National University, Korea), Seung-Hoon Baek (Kyungpook National University, Korea)
15:00-15:25 Effects of Anabolics on Bone: Bridging the Gap between Clinical Trials and Real-World Practice Ha Young Kim (University of Ulsan, Korea)
15:25-15:50 Transforming Fracture Care: Paradigm Shifts with Anabolic Therapies Jae Hyuk Yang (Korea University, Korea)
15:50-16:15 Anabolics in Cancer Patients: To Use or Not to Use? A Ram Hong (Chonnam National University, Korea)
Day 3
May 31(Sat)
15:00-16:15
Symposium 7. Rewiring Muscle Biology: From Stem Cells to Therapeutic Innovations
Room 2
Chair(s)
Yun-Sil Lee (Seoul National University, Korea), Dongryeol Ryu (GIST, Korea)
15:00-15:25 Thermogenesis in Muscle and Brown Fat Xingxing Kong (Fudan University, China)
15:25-15:50 The Aging Body Plan Miguel A. Esteban (Chinese Academy of Sciences, China)
15:50-16:15 Circulating Pro-Aging Factors in Sarcopenia: Biomarker Potential and Therapeutic Perspective Beom-Jun Kim (University of Ulsan, Korea)
Day 3
May 31(Sat)
15:00-16:15
Working Group 4. Dental and Craniofacial Working Group K
Updated Position of MRONJ, Dental Perspectives Room 3
Chair(s)
Yong-Dae Kwon (Kyung Hee University, Korea)
15:00-15:25 Recent Update of Local Risk Factors for MRONJ Jae-Young Kim (Yonsei University, Korea)
15:25-15:50 Adjunctive Therapies and Risk-Minimizing Surgical Strategies in MRONJ Management Moon-Young Kim (Dankook University, Korea)
15:50-16:15 Management of Recurrent MRONJ and Resuming Antiresorptive Therapy Jun-Young Kim (Yonsei University, Korea)
Sponsors By

Korean Society for Bone and Mineral Research (KSBMR)

#1001, Hyundai Kirim Bldg, 42, Seocho-daero 78-gil, Seocho-gu, Seoul, 06626, Korea

T. +82-2-3473-2230~1 | E. ksbmr@ksbmr.org

Business Registration Number: 106-82-62498

Name of Representative: Ki-Hyun Baek

SSBH 2025 Secretariat (PLANDO)

#615, 220, Gonghang-daero, Gangseo-gu, Seoul, 07806, Republic of Korea

T. +82-2-6734-1007 | E. info@ssbh.co.kr